These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 470233

  • 21. [Various indicators of the anticoagulation system in children with chronic glomerulonephritis].
    Zakharchenko LP.
    Vopr Okhr Materin Det; 1976 Aug; 21(8):41-4. PubMed ID: 997365
    [No Abstract] [Full Text] [Related]

  • 22. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
    Conte J, Boneu B, Mignon-Conte, Suc JM.
    Perspect Nephrol Hypertens; 1973 Aug; 1 Pt 2(0):915-26. PubMed ID: 4807811
    [No Abstract] [Full Text] [Related]

  • 23. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z, Dyr IE.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Aug; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract] [Full Text] [Related]

  • 24. [Standarization of the staphylococcal clumping test (SCT) for the detection of fibrinogen/fibrin degradation products (FDP) in serum (author's transl)].
    Contreras P, Salazar R.
    Rev Med Chil; 1975 Aug; 103(8):551-4. PubMed ID: 1197971
    [No Abstract] [Full Text] [Related]

  • 25. [Blood coagulation and fibrinolysis in patients with renal diseases (author's transl)].
    Yamabe H.
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):219-31. PubMed ID: 470232
    [No Abstract] [Full Text] [Related]

  • 26. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG, Momot AP, Cherkashin GV.
    Ter Arkh; 1984 May; 56(6):106-9. PubMed ID: 6474366
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA, Ignashenkova GV, Kitaev MI.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987 May; 10(1):18-21. PubMed ID: 3300697
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [The inhibition of coagulation in cord plasma (author's transl)].
    Kirchhof BR, Hoheisel M, Keefer L, Hemker HC.
    Z Geburtshilfe Perinatol; 1979 Apr; 183(2):163-8. PubMed ID: 442731
    [Abstract] [Full Text] [Related]

  • 34. Coagulation and fibrinolytic properties of peripheral venous blood in chronic ectopic pregnancy.
    Carty MJ, Barr RD, Ouna N.
    S Afr Med J; 1976 Jul 10; 50(29):1147-8. PubMed ID: 959930
    [Abstract] [Full Text] [Related]

  • 35. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP.
    N Z Med J; 1977 Oct 12; 86(597):332-4. PubMed ID: 272538
    [Abstract] [Full Text] [Related]

  • 36. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T, Magari Y, Kamberi P, Ishii T, Tomo T, Yasumori R, Nasu M.
    Clin Nephrol; 1995 Aug 12; 44(2):91-5. PubMed ID: 8529315
    [Abstract] [Full Text] [Related]

  • 37. [The usefullness of the fibrinogen degradation products (FDP) determination in the serum and urine in diagnostics and evaluation of effectiveness of therapy of nephropathy (author's transl)].
    Kwiecien-Głowacka E.
    Przegl Lek; 1981 Aug 12; 38(3):335-40. PubMed ID: 7244292
    [No Abstract] [Full Text] [Related]

  • 38. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL, Genth K.
    Internist (Berl); 1984 Feb 12; 25(2):93-101. PubMed ID: 6231262
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
    Nagake Y, Makino H, Yorioka N, Nomura S, Osawa G, Yamakido M, Kawasaki H, Kato Y, Matsuzaki M, Shikata K, Uemasu J, Somiya H, Fujii Z, Hayashida S, Nasu T, Oyabu Y, Nitta Y, Kawanishi H, Usui K, Fujiwara K, Takasugi N, Kanehara K, Hamaguchi N, Kumagai I, Ota Z.
    Nihon Jinzo Gakkai Shi; 1997 Jul 12; 39(5):474-82. PubMed ID: 9283213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.